期刊文献+

通过ROC曲线评估联合检测TnI、hs-CRP和NT-proBNP对老年急性冠状动脉综合征的诊断价值 被引量:6

Diagnostic value of combined measurement of TnI,hs-CRP and NT-proBNP by ROC curve in elderly patients with acute coronary syndrome
原文传递
导出
摘要 目的:通过ROC曲线探讨肌钙蛋白I(TnI)、超敏C反应蛋白(hs-CRP)和N末端脑利钠肽前体(NT-proBNP)联合检测在老年急性冠状动脉(冠脉)综合征(ACS)临床诊断中的应用价值。方法:收集不稳定型心绞痛(UA组,60例)、非ST段抬高型心肌梗死(NSTEMI组,61例)、ST段抬高性心肌梗死(STEMI组,59例)患者及健康者(对照组,60例)血清样本,用化学发光免疫法检测TnI,电化学发光免疫法检测NT-proBNP,速率散射免疫比浊法测定hs-CRP;绘制ROC曲线并建立Logistic回归模型,分析各指标单独和联合检测在UA、NSTEMI及STEMI诊断中的作用。结果:除UA组TnI外,ACS 3个组中血清TnI、hs-CRP与NT-proBNP值显著高于对照组(P<0.05);与单独检测相比,3项指标联合检测时,UA组、NSTEMI组和STEMI组ROC曲线下面积(AUC)[(0.858±0.051)、(0.988±0.013)和(0.998±0.004)]最大,灵敏度(57.8%、95.9%和99.1%)和特异度(94.7%、100.0%和100.0%)也最好。结论:联合检测TnI、hs-CRP和NT-proBNP有助于老年ACS中UA的诊断,对NSTEMI与STEMI的灵敏度和特异度也能达到最优化,但对区分NSTEMI和STEMI效果不明显。 Objective:To evaluate the value of combined measurement of TnI,hs-CRP and NT-proBNP in the clinical diagnosis of acute coronary syndrome(ACS) for elderly patients by ROC curve. Method:Collected adequate serum samples from unstable angina(UA) group(n=60),non-ST elevations myocardial infarction(NSTEMI) group(n=61),ST elevations myocardial infarction(STEMI) group(n=59) and healthy control group(n=60).TnI was detected by chemiluminescent immunoassay,NT-proBNP by electrochemistry luminescentce immunoassay,and hs-CRP by rate scattering immunoturbidimetric assay.Then analysis the value of combined measurement of TnI,hs-CRP and NT-proBNP in UA,NSTEMI,and STEMI diagnosis by ROC curve and Logistic regression model. Result:Except for TnI in UA group,the serum levels of TnI,hs-CRP and NT-proBNP in 3 ACS groups were significantly higher than those in healthy control group(both P〈0.05).Compared to test alone,combined measurement had bigger area under the ROC curve(AUC) in UA,NSTEMI and STEMI group [(0.858±0.051),(0.988±0.013),(0.998±0.004)],as well as better sensitivity and specificity(57.8%,94.7%;95.9%,100.0%;99.1%,100.0%). Conclusion:Combined measurement of TnI,hs-CRP and NT-proBNP can significantly improve the diagnosis of UA for elderly patients,and achieve the best sensitivity and specificity for NSTEMI and STEMI,but the effect of distinguishing between NSTEMI and STEMI is little.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2012年第9期667-670,共4页 Journal of Clinical Cardiology
关键词 冠状动脉综合征 急性 肌钙蛋白I 超敏C反应蛋白 N末端脑利钠肽前体 coronary syndrome,acute troponin I high sensitivity C-reactive protein N terminal pro-brain natriuretic peptide
  • 相关文献

参考文献7

  • 1闫小菊,刘松,黄玉晓.血浆和肽素与急性心肌梗死患者近期预后的关系[J].临床心血管病杂志,2011,27(9):680-682. 被引量:12
  • 2CORREIA L C, ESTEVES J P. C-reactive protein and outcomes in acute coronary syndromes: a system- atic review and meta-analysis[J]. Arq Bras Cardiol, 2011,97:76-85.
  • 3秦海斌,刘启明,印茂峰,方臻飞,赵水平,张利.长正五聚蛋白-3与高敏C反应蛋白在急性冠状动脉综合征的变化及意义[J].临床心血管病杂志,2011,27(7):491-493. 被引量:4
  • 4MORA S, GLYNN R J, HSIA J, et al. Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive pro- tein or dyslipidemia: results from the Justi{ication or the Use of Statins in Prevention: An Intervention Tri- al Evaluating Rosuvastatin (JUPITER) and meta-a- nalysis of women from primary prevention trials[J].Circulation,2010,121 : 1069-1077.
  • 5李晓涛,夏岳,郭喜朝,魏立业,戚国庆.血浆和肽素、B型利钠肽水平与慢性心力衰竭的关系[J].临床心血管病杂志,2011,27(4):268-270. 被引量:62
  • 6RIEZEBOS R K, LAARMAN G J, TIJSSEN J G, et al. The value of N-terminal proB-type natriuretic pep- tide for early identification of myocardial infarction in patients with high-risk non-ST-elevation acute coro- nary syndromes[J]. Clin Chem Lab Med, 2011,49:1359-1365.
  • 7FROHLICH G M, SCHOCH B, SCHMID F, et al. Takotsubo cardiomyopathy has a unique cardiac bio- marker profile: NT-proBNP/myoglobin and NT- proBNP/troponin T ratios for the differential diagno- sis of acute coronary syndromes and stress induced cardiomyopathy[J]. Int J Cardiol, 2012, 154: 328- 332.

二级参考文献22

  • 1WHITE H D,NORRIS R M,BROWN M A,et al.Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction[J].Circulation,1987,76:44-51.
  • 2STOISER B,M(E)RTL D,H(U)LSMANN M,et al.Copeptin,a fragment of the vasopressin precursor,as a novel predictor of outcome in heart failure[J].Eur J Clin Invest,2006,36:771-778.
  • 3GEGENHUBER A,STRUCK J,DIEPLINGER B,et al.Comparative evaluation of B-type natriuretic peptide,mid-regional proA-type natriuretic peptide,mid-regional pro-adrenomedullin,and Copeptin to predict 12 year mortality in patients with acute destabilized heart failure[J].J Card Fail,2007,13:42-49.
  • 4NEUHOLD S,HUELSMANN M,STRUNK G,et al.Comparison of copeptin,B-type natriuretic peptide,and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure:prediction of death at different stages of the disease[J].J Am Coll Cardiol,2008,52:266-272.
  • 5MAISEL A S,KRISHNASWAMY P,NOWAK R M,et al.Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of hear failure[J].New Engl Med,2002,347:161-167.
  • 6MORGENTHALER N G,STRUCK J,ALONSO C,et al.Assay for the measurement of copeptin,a stable peptide derived from the precursor of vasopressin[J].Clin Chem,2006,52:112-119.
  • 7KHAN S Q, DHILLON Q S, O'BRIEN R J, et al. C-Terminal provasopressin (Copeptin) as a novel and prognostic marker in acute myocardial infarction:Leicester Acute MyocardialInfarctionPeptide (LAMP) Study[J]. Circulation, 2007,115 : 2103 - 2110.
  • 8REICHLIN T, HOCHHOLZER W, STELZIG C, et al. Incremental value of copeptin for rapid rule out of acute myocardial infarction[J]. J Am Coll Cardiol, 2009,54:60-68.
  • 9KELLER T, TZIKAS S, ZELLER T, et al. Copeptin improves early diagonisis of acute myocardial in- farction[J].J Am Coll Cardiol,2010,55:2096-2106.
  • 10VOORS A A, HAEHLING S, ANKER S D, et al. C- terminal provasopressin (Copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study[J]. Eur Heart J,2009,30..1187-1194.

共引文献73

同被引文献45

引证文献6

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部